All Type of News
Multinationals challenge with new products
Multinational pharmaceutical firms are seeking to rock the domestic market with 20-odd new drugs, although the successful listing of these medicines into the national health insurance appears to be uncertain.
Pfize...
Drug makers call for consistent pharmaceuticals-related policy
Domestic pharmaceutical firms demanded the government establish more predictable and consistent regulations over pharmaceuticals with a sufficient grace period, which will become a key to sharpen their competitiveness...
A pharmacy covers average 2,287 senior citizens under medical security
A pharmacy covers 2,287 senior people benefiting from medical security as of Dec. 2006, according to data released by the National Health Insurance Corporation.
The data also found that a pharmacist cares for 1,576...
Hwang named AZK CFOHwang Jung-wook, former Chief Financial Officer (CFO) of Pizza Hut Korea, has been appointed CFO of AstraZeneca Korea as of Jan. 1, 2008 to ensure its sustained growth and beef ...
|
Kolon Pharm appoints Lee as new presidentKolon Pharm said it appoints Lee Woo-suk as a new president as of January 1, 2008 as part of its efforts to boost its pharmaceutical business.
As a graduate of Seoul National...
|
Will wave of Lotte's functional gum hit pharmacy market?
Lotte Confectionary released its newest functional gum, which is promoted protect the teeth, but the customer reaction has not so good so far, according to Yakup Shinmoon.
In a survey of 7 pharmacies in Seoul via p...
Dong-A eyes unified distribution over 5 OTCs
Dong-A Pharmaceutical Co. plans to conduct a unified distribution for its five OTC products with larger market share, such as Panpyrin, Circulan, Bigen, Bigencreamton and Hanobac in an attempt to provide better pharma...
GCC aims for W520 billion sales
Green Cross Corporation says it is targeting 520 billion won in sales this year, compared with last year's 44.2 billion won.
The company will strengthen brand recognition of flagship prescription drugs from nasal-s...
KFDA approves Retisert for treatment of affecting posterior segment of eye
The Korea Food and Drug Administration says it has approved Bausch & Lomb's Retisert (fluocinolone acetonide) 0.59 mg, the world's first intravitreal drug implant for the treatment of chronic non-infectious uveitis af...
Han renamed KIT chief
Han Sang-seop, has been reappointed head of the Korea Institute of Toxicology (KIT) on January 1. He will assume the post until 2010.
KIT, under the wing of the Korea Research Institute of Chemical Technology, is i...
